Jove
Visualize
Contact Us

Related Concept Videos

Obesity01:24

Obesity

671
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
671
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

8
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
8
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

6
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
6
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

5
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
5
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

234
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
234
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

2.1K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alterations in antioxidant minerals and oxidative stress biomarkers with altitude among young Indian males.

International journal of biometeorology·2026
Same author

Establishing Molecular Mechanism of Carnosine Against Hypobaric Hypoxia Induced Muscle Protein Loss via In-Silico and In-Vivo Approach.

Journal of biochemical and molecular toxicology·2026
Same author

miR-320-3p regulates apelin and TGF-β/SMAD3 signaling in hypobaric hypoxia exposed rats to induce skeletal muscle atrophy.

Journal of physiology and biochemistry·2025
Same author

miRNA and leptin signaling in metabolic diseases and at extreme environments.

Pharmacology research & perspectives·2024
Same author

Myokines: A central point in managing redox homeostasis and quality of life.

BioFactors (Oxford, England)·2024
Same author

Increased Expression of MiRNA-1 Contributes to Hypobaric Hypoxia-Induced Skeletal Muscle Loss.

Advanced biology·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Oct 4, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

431

Obesity: A Risk Factor for COVID-19.

Sukanya Srivastava1, Richa Rathor1, Somnath Singh1

  • 1Cellular Biochemistry Division, Defence Institute of Physiology and Allied Sciences, Delhi, India.

Advances in Experimental Medicine and Biology
|February 8, 2022
PubMed
Summary

Obesity is a significant risk factor for severe COVID-19 outcomes and mortality. Individuals with a high body mass index (BMI) face a greater risk of critical illness and death from SARS-CoV-2 infection.

Keywords:
COVID-19Immune dysregulationInflammationObesity

More Related Videos

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

985
An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

668

Related Experiment Videos

Last Updated: Oct 4, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

431
A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

985
An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

668

Area of Science:

  • Medical Science
  • Public Health

Background:

  • Emerging data link COVID-19 mortality to comorbidities like diabetes and hypertension.
  • Obesity is an underlying risk factor in patients with these comorbid conditions.
  • The specific adverse health effects of obesity and its role in COVID-19 mortality remain underexplored.

Purpose of the Study:

  • To investigate the potential role of enhanced fat deposition (obesity) as a risk factor for increased mortality in COVID-19 patients.
  • To systematically review and highlight the link between obesity and associated risks in COVID-19.

Main Methods:

  • Literature review and information collection from online databases (PubMed, Google Scholar, ResearchGate).

Main Results:

  • Studies from France, New York, and Mexico indicate individuals with a body mass index (BMI) ≥35 kg/m² or >40 kg/m² have a higher risk of critical COVID-19 illness.
  • This increased risk of critical illness directly correlates with higher mortality rates in obese individuals.

Conclusions:

  • Obesity, across all life stages (childhood, adolescence, adulthood), is a profound risk factor for COVID-19 susceptibility and severity.
  • Obesity-associated alterations in nutritional, lifestyle, cardiac, respiratory, renal, and immunological functions may potentiate SARS-CoV-2 complications.
  • Monitoring BMI is recommended during the pandemic to identify individuals at higher risk.